Brainard David sold $29K of EVER

Brainard David (Chief Technology Officer) sold 1,097 shares of EverQuote, Inc. (EVER) at $26.47 on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brainard David
Published Aug 27, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Neutral
high confidence
Mentioned
$EVER
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERNeutralLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, suggesting limited market impact.

02

Market read

Routine insider sale with minimal effect on EverQuote's stock price.

03

What to watch

The sale was pre‑arranged under a 10b5‑1 plan, reducing the likelihood of negative sentiment.

Relevance 2/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions; traders monitor them for potential signals.

Company-level read

Ticker impact

$EVERNeutralHigh confidence
Context

CTO sold 1,097 shares for $29K via a 10b5-1 plan, reducing his stake to 163,030 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size is small relative to market cap and typical insider trading volumes.

Market effects

None; the transaction is company‑specific and does not affect the broader tech sector.

None; only U.S. investors may note the insider sale.

None

Counterpoint

Even small insider sales can signal concerns, but here the amount is trivial.

Key entities

  • EverQuote, Inc.

    Online insurance marketplace listed on NASDAQ under EVER.

  • David Brainard

    Chief Technology Officer of EverQuote.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.